{"title": "Vaccine Therapy Plus QS21 en el tratamiento de pacientes con c\u00e1ncer pancre\u00e1tico o colorrectal avanzado", "author": null, "url": "https://ichgcp.net/es/clinical-trials-registry/NCT00006387", "hostname": "ichgcp.net", "description": "FUNDAMENTO: Las vacunas pueden hacer que el cuerpo genere una respuesta inmunitaria para destruir las c\u00e9lulas tumorales. QS21 puede mejorar la capacidad del sis.... Registro de ensayos cl\u00ednicos. ICH GCP.", "sitename": "ichgcp.net", "date": "2000-10-04", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Vaccine Therapy Plus QS21 en el tratamiento de pacientes con c\u00e1ncer pancre\u00e1tico o colorrectal avanzado\n[Fox Chase Cancer Center](https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Fox%20Chase%20Cancer%20Center)\nUn estudio de fase I de vacunaci\u00f3n con p\u00e9ptido RAS en pacientes con adenocarcinoma pancre\u00e1tico o colorrectal avanzado\nFUNDAMENTO: Las vacunas pueden hacer que el cuerpo genere una respuesta inmunitaria para destruir las c\u00e9lulas tumorales. QS21 puede mejorar la capacidad del sistema inmunol\u00f3gico para responder a la enfermedad. La combinaci\u00f3n de la terapia de vacuna con QS21 puede destruir m\u00e1s c\u00e9lulas tumorales.\nPROP\u00d3SITO: Ensayo de fase I para estudiar la eficacia de la terapia con vacunas m\u00e1s QS21 en el tratamiento de pacientes con c\u00e1ncer de p\u00e1ncreas o colorrectal avanzado.\nDescripci\u00f3n general del estudio\nEstado\nCondiciones\nIntervenci\u00f3n / Tratamiento\nDescripci\u00f3n detallada\nOBJETIVOS: I. Determinar la toxicidad de la vacuna contra el c\u00e1ncer de p\u00e9ptido ras m\u00e1s el adyuvante inmunol\u00f3gico QS21 en pacientes con adenocarcinoma pancre\u00e1tico o colorrectal avanzado. II. Determinar los efectos inmunol\u00f3gicos de este r\u00e9gimen de tratamiento en estos pacientes. tercero Determinar el efecto antitumoral de este r\u00e9gimen de tratamiento en estos pacientes.\nESQUEMA: Este es un estudio de escalada de dosis de la vacuna contra el c\u00e1ncer de p\u00e9ptido ras. Los pacientes reciben la vacuna contra el c\u00e1ncer de p\u00e9ptido ras mezclada con adyuvante inmunol\u00f3gico QS21 por v\u00eda subcut\u00e1nea mensualmente por 4 dosis, cada 2 meses por 4 dosis, cada 4 meses por 3 dosis, cada 6 meses por 2 dosis y luego anualmente en ausencia de toxicidad inaceptable. Cohortes de 3 a 6 pacientes reciben dosis crecientes de la vacuna contra el c\u00e1ncer de p\u00e9ptido ras hasta que se determina la dosis m\u00e1xima tolerada (MTD). La MTD se define como la dosis anterior a la que al menos 2 de 3 o 2 de 4 pacientes experimentan toxicidad limitante de la dosis.\nACUMULACI\u00d3N PROYECTADA: Aproximadamente 15-20 pacientes se acumular\u00e1n para este estudio dentro de los 30 meses.\nTipo de estudio\nInscripci\u00f3n (Actual)\nFase\n- Fase 1\nCriterios de participaci\u00f3n\nCriterio de elegibilidad\nEdades elegibles para estudiar\nAcepta Voluntarios Saludables\nG\u00e9neros elegibles para el estudio\nDescripci\u00f3n\nCARACTER\u00cdSTICAS DE LA ENFERMEDAD: Adenocarcinoma pancre\u00e1tico o colorrectal avanzado confirmado histol\u00f3gicamente Inextirpable curativamente O Recurrente despu\u00e9s de una resecci\u00f3n potencialmente curable O Adenocarcinoma pancre\u00e1tico que ha sido extirpado quir\u00fargicamente en los \u00faltimos 12 meses Debe tener una de las siguientes mutaciones del gen ras en el cod\u00f3n 12: Glicina a ciste\u00edna Glicina a asp\u00e1rtico \u00e1cido Glicina a valina Se requiere HLA A2 si hay evidencia de restricci\u00f3n HLA para la presentaci\u00f3n del p\u00e9ptido\nCARACTER\u00cdSTICAS DEL PACIENTE: Edad: 18 a\u00f1os o m\u00e1s Estado funcional: ECOG 0-2 Esperanza de vida: Al menos 3 meses Hematopoy\u00e9tico: WBC al menos 3500/mm3 Recuento de linfocitos al menos 500/mm3 Hep\u00e1tico: Bilirrubina no mayor a 3 mg/dL Renal: Creatinina no m\u00e1s de 2 veces el l\u00edmite superior de lo normal O aclaramiento de creatinina de al menos 50 ml/min Otro: Sin infecci\u00f3n activa que requiera tratamiento sist\u00e9mico Sin antecedentes de alergia grave o anafilaxia Sin inmunodeficiencia (p. ej., infecci\u00f3n por VIH, lupus o mieloma) No embarazada Embarazo negativo prueba Los pacientes f\u00e9rtiles deben utilizar m\u00e9todos anticonceptivos efectivos Las mujeres deben utilizar m\u00e9todos anticonceptivos durante los 3 meses anteriores, durante y durante los 3 meses posteriores al estudio Los hombres deben utilizar m\u00e9todos anticonceptivos durante los 3 meses posteriores al estudio\nTERAPIA CONCURRENTE ANTERIOR: Terapia biol\u00f3gica: Al menos 4 semanas desde la terapia inmunol\u00f3gica previa Sin otra inmunoterapia sist\u00e9mica concurrente para el c\u00e1ncer Quimioterapia: Al menos 4 semanas desde la quimioterapia previa Sin quimioterapia sist\u00e9mica concurrente para el c\u00e1ncer Terapia endocrina: Al menos 4 semanas desde la administraci\u00f3n previa de corticosteroides Sin corticosteroides concurrentes Radioterapia: al menos 4 semanas desde la radioterapia anterior Cirug\u00eda: consulte Caracter\u00edsticas de la enfermedad Otros: al menos 4 semanas desde la administraci\u00f3n previa de inmunosupresores (p. ej., metotrexato) Sin inmunosupresores concurrentes Se permiten medicamentos antiinflamatorios no esteroideos concurrentes para paliar el dolor\nPlan de estudios\n\u00bfC\u00f3mo est\u00e1 dise\u00f1ado el estudio?\nDetalles de dise\u00f1o\n- Prop\u00f3sito principal: Tratamiento\n- Asignaci\u00f3n: N / A\n- Modelo Intervencionista: Asignaci\u00f3n de un solo grupo\nColaboradores e Investigadores\nPatrocinador\nColaboradores\nInvestigadores\n- Silla de estudio: Neal J. Meropol, MD, Fox Chase Cancer Center\nFechas de registro del estudio\nFechas importantes del estudio\nInicio del estudio\nFinalizaci\u00f3n primaria (Actual)\nFinalizaci\u00f3n del estudio (Actual)\nFechas de registro del estudio\nEnviado por primera vez\nPrimero enviado que cumpli\u00f3 con los criterios de control de calidad\nPublicado por primera vez (Estimar)\nActualizaciones de registros de estudio\n\u00daltima actualizaci\u00f3n publicada (Estimar)\n\u00daltima actualizaci\u00f3n enviada que cumpli\u00f3 con los criterios de control de calidad\n\u00daltima verificaci\u00f3n\nM\u00e1s informaci\u00f3n\nT\u00e9rminos relacionados con este estudio\nPalabras clave\nT\u00e9rminos MeSH relevantes adicionales\n-\n[Enfermedades del Sistema Digestivo](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Digestive%20System%20Diseases)\n-\n[Neoplasias por tipo histol\u00f3gico](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Neoplasms%20by%20Histologic%20Type)\n-\n[Neoplasias](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Neoplasms)\n-\n[Neoplasias por sitio](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Neoplasms%20by%20Site)\n-\n[Carcinoma](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma)\n-\n[Neoplasias Glandulares y Epiteliales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Neoplasms%2C%20Glandular%20and%20Epithelial)\n-\n[Enfermedades del sistema endocrino](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Endocrine%20System%20Diseases)\n-\n[Neoplasias Gastrointestinales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Gastrointestinal%20Neoplasms)\n-\n[Neoplasias del Sistema Digestivo](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Digestive%20System%20Neoplasms)\n-\n[Enfermedades Gastrointestinales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Gastrointestinal%20Diseases)\n-\n[Neoplasias de gl\u00e1ndulas endocrinas](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Endocrine%20Gland%20Neoplasms)\n-\n[Enfermedades del Colon](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colonic%20Diseases)\n-\n[Enfermedades intestinales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Intestinal%20Diseases)\n-\n[Neoplasias Intestinales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Intestinal%20Neoplasms)\n-\n[Enfermedades Rectales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Rectal%20Diseases)\n-\n[Enfermedades pancre\u00e1ticas](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pancreatic%20Diseases)\n-\n[Neoplasias colorrectales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colorectal%20Neoplasms)\n-\n[Adenocarcinoma](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Adenocarcinoma)\n-\n[Neoplasias pancre\u00e1ticas](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pancreatic%20Neoplasms)\nOtros n\u00fameros de identificaci\u00f3n del estudio\n- FCCC-98026\n- NCI-T97-0051 (Otro n\u00famero de subvenci\u00f3n/financiamiento: NCI)\nEsta informaci\u00f3n se obtuvo directamente del sitio web\n[clinicaltrials.gov](https://clinicaltrials.gov) sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comun\u00edquese con [register@clinicaltrials.gov](mailto:register@clinicaltrials.gov). Tan pronto como se implemente un cambio en [clinicaltrials.gov](https://clinicaltrials.gov), tambi\u00e9n se actualizar\u00e1 autom\u00e1ticamente en nuestro sitio web. .\nEnsayos cl\u00ednicos sobre C\u00e1ncer colonrectal\n-\nNCT06040541ReclutamientoTumores s\u00f3lidos avanzados | C\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as (CPCNP) | Adenocarcinoma ductal pancre\u00e1tico (PDAC) | C\u00e1ncer colorrectal (CCR)\n-\nNCT06039202A\u00fan no reclutando\n-\nNCT06040632ReclutamientoC\u00e1ncer colonrectal | P\u00f3lipo colorrectal | C\u00e1ncer colorrectal Etapa I\n-\nNCT06036563A\u00fan no reclutando\n[Detecci\u00f3n prospectiva y diferenciaci\u00f3n de c\u00e1nceres comunes mediante secuenciaci\u00f3n de ADN sin c\u00e9lulas de sangre perif\u00e9rica](https://ichgcp.net/es/clinical-trials-registry/NCT06036563)C\u00e1ncer de mama | C\u00e1ncer g\u00e1strico | C\u00e1ncer colonrectal | C\u00e1ncer de p\u00e1ncreas | C\u00e1ncer de h\u00edgado | C\u00e1ncer de es\u00f3fago | Diagn\u00f3stico de c\u00e1ncer | C\u00e1ncer de pulm\u00f3n\n-\nNCT06037954ReclutamientoC\u00e1ncer de mama | C\u00e1ncer colonrectal | C\u00e1ncer de pulm\u00f3n | Cancer de prostata\n-\nNCT06032338A\u00fan no reclutando\n-\nNCT06034197A\u00fan no reclutando\n-\nNCT06028516ReclutamientoC\u00e1ncer colonrectal | Cirug\u00eda | Efecto de la quimioterapia\n-\nNCT06029010A\u00fan no reclutando\n-\nNCT06028724Reclutamiento\n[Un estudio observacional prospectivo sobre la prevalencia de mutaciones cl\u00ednicamente \u00fatiles en tumores s\u00f3lidos caracterizados por m\u00e9todos de secuenciaci\u00f3n de pr\u00f3xima generaci\u00f3n en an\u00e1lisis de biopsia l\u00edquida (POPCORN) (POPCORN)](https://ichgcp.net/es/clinical-trials-registry/NCT06028724)Melanoma | C\u00e1ncer de cuello uterino | C\u00e1ncer de mama | C\u00e1ncer g\u00e1strico | Cancer de pancreas | C\u00e1ncer de ovarios | Tumor solido | C\u00e1ncer de las v\u00edas biliares | Tumor s\u00f3lido avanzado | C\u00e1ncer endometrial\nEnsayos cl\u00ednicos sobre vacuna contra el c\u00e1ncer de p\u00e9ptido ras\n-\nNCT00019006TerminadoC\u00e1ncer de p\u00e1ncreas recurrente | C\u00e1ncer de p\u00e1ncreas en estadio III | C\u00e1ncer de pulm\u00f3n de c\u00e9lulas peque\u00f1as en estadio extenso | C\u00e1ncer de colon recurrente | C\u00e1ncer de recto recurrente | C\u00e1ncer de p\u00e1ncreas en estadio II | C\u00e1ncer de p\u00e1ncreas en estadio IVA | C\u00e1ncer de p\u00e1ncreas en estadio IVB | C\u00e1ncer de p\u00e1ncreas en estadio I | C\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as en estadio II\n-\nNCT00019084TerminadoC\u00e1ncer de cuello uterino | C\u00e1ncer de mama | C\u00e1ncer colonrectal | Cancer de pancreas | C\u00e1ncer de ovarios | C\u00e1ncer de pulm\u00f3n\n-\nNCT00019331Terminado\n[Terapia de vacuna m\u00e1s terapia biol\u00f3gica en el tratamiento de adultos con tumores s\u00f3lidos metast\u00e1sicos](https://ichgcp.net/es/clinical-trials-registry/NCT00019331)Tumor testicular de c\u00e9lulas germinales | C\u00e1ncer de cabeza y cuello | C\u00e1ncer colonrectal | Cancer de pancreas | C\u00e1ncer de pulm\u00f3n | Tumor s\u00f3lido adulto no especificado, protocolo espec\u00edfico | C\u00e1ncer endometrial | Melanoma (piel) | C\u00e1ncer de h\u00edgado\n-\nNCT00019591Terminado\n-\nNCT00005630Terminado\n-\nNCT00003959TerminadoS\u00edndromes mielodispl\u00e1sicos | Leucemia", "language": null, "image": null, "pagetype": "website", "links": ["https://ichgcp.net/es", "#", "https://ichgcp.net/de", "https://ichgcp.net/", "https://ichgcp.net/es", "https://ichgcp.net/fr", "https://ichgcp.net/it", "https://ichgcp.net/pt", "https://ichgcp.net/ru", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/ich-e-group-of-guidelines", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/events", "https://ichgcp.net/es/clinical-trials-registry/publications", "https://ichgcp.net/es/clinical-trials-registry/researchers", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/clinical-trials-registry/NCT00006387", "https://telegram.me/share/url?url=https://ichgcp.net/es/clinical-trials-registry/NCT00006387&text=", "https://twitter.com/intent/tweet?url=https://ichgcp.net/es/clinical-trials-registry/NCT00006387", "https://ichgcp.net/es", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Fox%20Chase%20Cancer%20Center", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colorectal%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pancreatic%20Cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=ras%20peptide%20cancer%20vaccine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=QS21", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Fox%20Chase%20Cancer%20Center", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%20Cancer%20Institute%20%28NCI%29", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=adenocarcinoma%20of%20the%20rectum", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20IV%20rectal%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20IV%20colon%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=adenocarcinoma%20of%20the%20colon", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=recurrent%20colon%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=recurrent%20rectal%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=recurrent%20pancreatic%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=adenocarcinoma%20of%20the%20pancreas", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=stage%20IV%20pancreatic%20cancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Digestive%20System%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Neoplasms%20by%20Histologic%20Type", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Neoplasms%20by%20Site", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Neoplasms%2C%20Glandular%20and%20Epithelial", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Endocrine%20System%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Gastrointestinal%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Digestive%20System%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Gastrointestinal%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Endocrine%20Gland%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colonic%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Intestinal%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Intestinal%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Rectal%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pancreatic%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colorectal%20Neoplasms", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Adenocarcinoma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pancreatic%20Neoplasms", "https://clinicaltrials.gov", "mailto:register@clinicaltrials.gov", "https://clinicaltrials.gov", "https://ichgcp.net/es/clinical-trials-registry/NCT06040541", "https://ichgcp.net/es/clinical-trials-registry/NCT06039202", "https://ichgcp.net/es/clinical-trials-registry/NCT06040632", "https://ichgcp.net/es/clinical-trials-registry/NCT06036563", "https://ichgcp.net/es/clinical-trials-registry/NCT06037954", "https://ichgcp.net/es/clinical-trials-registry/NCT06032338", "https://ichgcp.net/es/clinical-trials-registry/NCT06034197", "https://ichgcp.net/es/clinical-trials-registry/NCT06028516", "https://ichgcp.net/es/clinical-trials-registry/NCT06029010", "https://ichgcp.net/es/clinical-trials-registry/NCT06028724", "https://ichgcp.net/es/clinical-trials-registry/NCT00019006", "https://ichgcp.net/es/clinical-trials-registry/NCT00019084", "https://ichgcp.net/es/clinical-trials-registry/NCT00019331", "https://ichgcp.net/es/clinical-trials-registry/NCT00019591", "https://ichgcp.net/es/clinical-trials-registry/NCT00005630", "https://ichgcp.net/es/clinical-trials-registry/NCT00003959", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%2BCancer%2BInstitute%2B%2528NCI%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Mayo%2BClinic", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Kaneka%2BAmericas%2BHolding%2BInc.", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Cairo%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=European%2BSociety%2Bof%2BHuman%2BReproduction%2Band%2BEmbryology", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidade%2Bde%2BLisboa%252C%2BPortugal", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=GlaxoSmithKline", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Medtronic%2BSurgical%2BTechnologies", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=M.D.%2BAnderson%2BCancer%2BCenter", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Novartis%2BPharmaceuticals", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Jos%25C3%25A9phine%2BSOLTANI%252C%2BCardiology%2Bdepartment%252C%2BVersailles%2BHospital", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Orphanetics%2BPharma%2BEntwicklungs%2BGmbH", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pediatric%2BOrthopaedic%2BSociety%2Bof%2BNorth%2BAmerica", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assistance%2BPublique%2B-%2BH%25C3%25B4pitaux%2Bde%2BParis", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidad%2Bdel%2BZulia", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=AstraZeneca", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pfizer", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=SeeCure%2BLLC", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assiut%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Center%2Bfor%2BIndustrial%2BTechnological%2BDevelopment%2Bof%2BSpain", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma%252C%2BAdrenal%2BCortical", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Depression", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Obesity", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=HIV%2BInfections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pain", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronary%2BArtery%2BDisease", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%2BI%2BGallbladder%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ultrasound%2BEvaluation", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Breast%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Postneoadjuvant%2BTherapy%2BStage%2BI%2BGastric%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colon%2BMalignant%2BTumor", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ankle%2BArthroplasty", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Post-traumatic%2BAnosmia", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stroke", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Malignant%2BNeoplasm%2Bof%2BRespiratory%2Band%2BIntrathoracic%2BOrgan%2BCarcinoma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Prostate%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Cushing%2527s%2BSyndrome%2BI", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Hypertension", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Esophageal%2BResection%2BCandidates", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asthma", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Docetaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Pilocarpine%2B1.25%2525%2BEye%2Bdrop", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Injectafer", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Valacyclovir%2Barrow", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Teicoplanin%2BSandoz%2B200%2Bmg%2Bpowder%2Band%2Bsolvent%2Bfor%2Bsolution%2Bfor%2Binjection%2Bor%2Binfusion%2Bor%2Boral%2Bsolution.", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cyclophosphamide", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Brimonidine%2Btartrate%2Bophthalmic%2Bsolution%2B0.025%2525%2B%2528n%2B%253D%2B56%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Alpelisib%2B150%2BMG%2BOral%2BTablet%2B%255BPiqray%255D", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Prednisone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cisplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Gemcitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Bevacizumab", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=MK-8521%2B100%25CE%25BCg", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Paclitaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Transplant%2B2%2BMelphalan", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=20mg%2BAzilsartan%2BTablets", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Capecitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Dexamethasone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Carboplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Oral%2BGlucose%2BGel", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/cro-list/country/bulgaria", "https://ichgcp.net/es/cro-list/country/cambodia", "https://ichgcp.net/es/cro-list/country/cameroon", "https://ichgcp.net/es/cro-list/country/ghana", "https://ichgcp.net/es/cro-list/country/iran", "https://ichgcp.net/es/cro-list/country/malta", "https://ichgcp.net/es/cro-list/country/mexico", "https://ichgcp.net/es/cro-list/country/papua_new_guinea", "https://ichgcp.net/es/cro-list/country/senegal", "https://ichgcp.net/es/cro-list/country/slovakia", "https://ichgcp.net/es/cro-list/country/south_africa", "https://ichgcp.net/es/cro-list/country/south_korea", "https://ichgcp.net/es/cro-list/country/turkmenistan", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/cro-list/country/tanzania/company/dokumeds", "https://ichgcp.net/es/cro-list/country/tanzania/company/sgs", "https://ichgcp.net/es/cro-list/country/tanzania/company/across_global", "https://ichgcp.net/es/cro-list/country/tanzania", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/ord_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_cat", "https://ichgcp.net/es", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/guideline-for-the-notification-of-serious-breaches-of-regulation-eu-no-536-2014", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/about-us-our-mission", "https://ichgcp.net/es/sitemap", "https://ichgcp.net/es/contact-us", "https://ichgcp.net/es/feed", "/privacy", "/disclaimer", "https://ichgcp.net/da/clinical-trials-registry/NCT00006387", "https://ichgcp.net/de/clinical-trials-registry/NCT00006387", "https://ichgcp.net/clinical-trials-registry/NCT00006387", "https://ichgcp.net/es/clinical-trials-registry/NCT00006387", "https://ichgcp.net/fr/clinical-trials-registry/NCT00006387", "https://ichgcp.net/it/clinical-trials-registry/NCT00006387", "https://ichgcp.net/hu/clinical-trials-registry/NCT00006387", "https://ichgcp.net/nl/clinical-trials-registry/NCT00006387", "https://ichgcp.net/no/clinical-trials-registry/NCT00006387", "https://ichgcp.net/pl/clinical-trials-registry/NCT00006387", "https://ichgcp.net/pt/clinical-trials-registry/NCT00006387", "https://ichgcp.net/fi/clinical-trials-registry/NCT00006387", "https://ichgcp.net/sv/clinical-trials-registry/NCT00006387", "https://ichgcp.net/cs/clinical-trials-registry/NCT00006387", "https://ichgcp.net/ru/clinical-trials-registry/NCT00006387", "https://ichgcp.net/ja/clinical-trials-registry/NCT00006387", "https://ichgcp.net/zh/clinical-trials-registry/NCT00006387", "https://ichgcp.net/ko/clinical-trials-registry/NCT00006387", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf"]}